首页> 外文学位 >Development of an enzyme immobilization platform based on microencapsulation for paper-based biosensors.
【24h】

Development of an enzyme immobilization platform based on microencapsulation for paper-based biosensors.

机译:基于微囊化的纸基生物传感器酶固定平台的开发。

获取原文
获取原文并翻译 | 示例

摘要

Biosensing paper attracts increasing attention due to its benefits of being simple, visible, portable and useful for detecting various contaminants, pathogens and toxins. While there has been no bioactive paper commercialized since glucose paper strips developed in the fifties, many research groups are working to immobilize biomolecules on paper to achieve a bioactive paper that is affordable and has good shelf life. The goal of this research is to develop some highly useful bioactive paper that could, for example, measure blood glucose, or immediately detect and simultaneously deactivate pathogens such as neuraminidase and E.coli. Previously, bioactive paper was produced either through physically absorbing biorecognition elements or printing bio-ink onto paper substrate. Our methodology for fabrication of bioactive paper strips is compatible with existing paper making process and includes three procedures: the fabrication of microcapsules, enzyme or antibody microencapsulation, immobilization of enzymes or antibody-entrapped microcapsules into paper pulp.;The first step, in fabricating of bioactive paper strips is to produce biocompatible and inexpensive microcapsules with suitable parameters. To do so, two types of microencapsulation methods were compared; the emulsion method and the vibration nozzle method accomplished with an encapsulator. The parameters for producing optimal microcapsules with both methods were studied. Factors that affect their diameter, wall thickness, shell pore size, encapsulation efficiency and membrane compositions were also discussed. By comparison, microcapsules prepared with poly(ethyleneimine) (PEI) by the emulsion method exhibit properties that were more suitable for enzyme encapsulation and paper making process, whereas the microcapsules prepared by the vibration nozzle method were too big to be immobilized within paper pulp, and had lower encapsulation efficiency, enzymatic activity and productivity. Thus the emulsion method was chosen for subsequent experiments such as enzyme and antibody microencapsulation and bacterial vaginosis (BV) paper preparation. Microcapsules made by the emulsion method were semi-permeable in that the diffusion of substrate and product molecules were allowed freely across the membranes but the encapsulated enzymes would be retained inside.;Glucose oxidase from Aspergillus niger (GOx) and laccase from Trametes versicolor (TvL) microcapsules showed high encapsulation efficiency, but the encapsulation process caused a severe decrease in the specific activities of both enzymes. Results from circular dichroism (CD) studies, fluorescence properties, enzymatic activities of free enzymes and Michaelis-Menten behavior demonstrated that the V max decrease for GOx was due to the restriction of diffusion across microcapsule membranes with pore size less than 5 nm. The microencapsulation process improved the thermal stability of GOx but decreased that of laccase.;Bioactive papers were fabricated either by incorporating microcapsules containing different enzymes or empty microcapsules soaked in substrate and enhancer solution into the paper pulp during the sheet making process. Both the GOx and the BV paper strips underwent a color change in the presence of glucose and potassium iodide, and sialidase from Clostridium perfringens respectively. Some preliminary studies on antibody sensitized microcapsules, in which antibody was either encapsulated within the PEI microcapsules or conjugated to its membranes, were also performed.;Our objective was to establish an enzyme immobilization platform based on microencapsulation techniques for paper based biosensors. Even though our current studies only focused on the microencapsulation of two enzymes, TvL and GOx, as well as the bioactive paper preparation, a similar approach can be applied to other enzymes. We believe that this immobilization method can potentially be employed for bioactive paper preparation on an industrial scale.
机译:生物传感纸由于其简单,可见,便携和可用于检测各种污染物,病原体和毒素的优点而吸引了越来越多的关注。自从五十年代开发出葡萄糖纸带以来,还没有生物活性纸商业化,但许多研究小组正在努力将生物分子固定在纸上,以实现价格合理且具有良好保质期的生物活性纸。这项研究的目的是开发一些高度有用的生物活性纸,例如,可以测量血糖,或立即检测并同时灭活神经氨酸酶和大肠杆菌等病原体。以前,生物活性纸是通过物理吸收生物识别元件或将生物墨水印刷到纸张基材上来生产的。我们制造生物活性纸带的方法与现有的造纸工艺兼容,包括三个步骤:微囊的制造,酶或抗体的微囊化,酶或包埋有酶或抗体的微囊固定到纸浆中的第一步;生物活性纸条用于生产具有合适参数的生物相容性和廉价微胶囊。为此,比较了两种类型的微囊化方法:乳剂法和振动喷嘴法是用密封剂完成的。研究了用两种方法生产最佳微胶囊的参数。还讨论了影响其直径,壁厚,壳孔尺寸,包封效率和膜组成的因素。相比之下,通过乳液法用聚乙烯亚胺(PEI)制备的微胶囊具有更适合酶包囊和造纸工艺的特性,而通过振动喷嘴法制备的微胶囊太大而无法固定在纸浆中,并且具有较低的包封效率,酶活性和生产率。因此,选择乳液法用于后续实验,例如酶和抗体微囊化以及细菌性阴道病(BV)纸的制备。乳液法制得的微囊是半透性的,因为基质和产物分子可以自由地跨膜扩散,但包封的酶可以保留在内部。黑曲霉(GOx)的葡萄糖氧化酶和云芝Trametes(TvL)的漆酶)微胶囊显示出高的包封效率,但包封过程导致两种酶的比活性严重降低。圆二色性(CD)研究,荧光特性,游离酶的酶活性和Michaelis-Menten行为的结果表明,GOx的V max降低是由于限制了孔径小于5 nm的微囊膜的扩散。微囊化工艺提高了GOx的热稳定性,但降低了漆酶的热稳定性。通过在造纸过程中将包含不同酶的微囊或浸泡在基质和增强剂溶液中的空微囊掺入纸浆中,制成生物活性纸。在葡萄糖和碘化钾以及产气荚膜梭菌的唾液酸酶存在下,GOx和BV纸条均发生了颜色变化。还进行了一些抗体敏化微囊的初步研究,其中抗体被封装在PEI微囊中或与膜结合。我们的目标是基于微囊技术为纸基生物传感器建立酶固定平台。即使我们目前的研究仅集中在两种酶(TvL和GOx)的微囊化以及生物活性纸的制备上,也可以将类似的方法应用于其他酶。我们认为,这种固定方法可以潜在地用于工业规模的生物活性纸制备。

著录项

  • 作者

    Zhang, Yufen.;

  • 作者单位

    Universite de Montreal (Canada).;

  • 授予单位 Universite de Montreal (Canada).;
  • 学科 Chemistry Analytical.
  • 学位 Ph.D.
  • 年度 2013
  • 页码 238 p.
  • 总页数 238
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号